Concentrix (CNXC) CEO Christopher Caldwell awarded 93,291 restricted units

Rhea-AI Filing Summary

Concentrix Corp reported that President and CEO Christopher A. Caldwell received an equity award in the form of restricted stock units. On 01/21/2026, he was granted 93,291 shares of common stock at a price of $0 per share, increasing his directly held beneficial ownership to 373,877 common shares after the award.

The filing explains that these 93,291 units are restricted stock units granted under the company’s 2020 Stock Incentive Plan. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of the first three anniversaries of the grant date, tying the CEO’s compensation to the company’s long‑term performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caldwell Christopher A

(Last) (First) (Middle)

39899 BALENTINE DRIVE

SUITE 235

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/21/2026		A		93,291(1)	A	$0	373,877	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units awarded under the 2020 Stock Incentive Plan. The restricted stock units vest as to one-third of the shares on each of the first three anniversaries of the grant date.

Remarks:

	/s/ Andrew A. Farwig, Attorney-in-Fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Concentrix (CNXC) report for January 21, 2026?

Concentrix reported that President and CEO Christopher A. Caldwell received an award of 93,291 shares of common stock on 01/21/2026, recorded at a $0 price per share as an equity grant rather than an open‑market purchase.

How many Concentrix (CNXC) shares does Christopher A. Caldwell own after this Form 4 transaction?

Following the reported equity award, Christopher A. Caldwell beneficially owns 373,877 shares of Concentrix common stock, held in direct ownership according to the filing.

What kind of equity award did the Concentrix (CNXC) CEO receive?

The filing states that the 93,291 shares represent restricted stock units granted under Concentrix’s 2020 Stock Incentive Plan, rather than immediately freely tradable common shares.

How do the new restricted stock units for the Concentrix (CNXC) CEO vest?

The restricted stock units vest in three installments: one‑third of the shares vest on each of the first three anniversaries of the grant date, linking full receipt of the shares to multi‑year service.

Was the Concentrix (CNXC) CEO’s Form 4 transaction a purchase or sale in the open market?

No open‑market trade is reported. The filing shows an “A” (acquisition) transaction code at a price of $0 per share, indicating an equity grant of restricted stock units rather than a market purchase or sale.

Who is the insider named in this Concentrix (CNXC) Form 4 filing and what is their role?

The reporting person is Christopher A. Caldwell, who is listed as both a Director and an Officer of Concentrix, serving as the company’s President and CEO.